Key Metrics
CiteScore 

16.3
H-Index 

179
Impact Factor 

10 - 15
SJR 

Q1Pharmacology (medical)

SNIP 

2.68
Recommended pre-submission checks
Powered by 

Topics Covered on Drugs
Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1971 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drugs
Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.
- 1 Jul 2026
- Drugs
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.
- 1 Jul 2026
- Drugs
Pixavir Marboxil: First Approval.
- 1 Jul 2026
- Drugs
Etripamil: First Approval.
- 1 Jul 2026
- Drugs
Reframing the High-density Lipoprotein (HDL) Hypothesis in Light of Clinical Trials of Cholesterol Ester Transfer Protein (CETP) Inhibitors.
- 1 Jul 2026
- Drugs
EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer: Current Treatment Landscape and Future Directions.
- 1 Jul 2026
- Drugs
Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.
- 1 Jul 2026
- Drugs
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.
- 1 Jul 2026
- Drugs
Pixavir Marboxil: First Approval.
- 1 Jul 2026
- Drugs
Etripamil: First Approval.
- 1 Jul 2026
- Drugs
Reframing the High-density Lipoprotein (HDL) Hypothesis in Light of Clinical Trials of Cholesterol Ester Transfer Protein (CETP) Inhibitors.
- 1 Jul 2026
- Drugs
EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer: Current Treatment Landscape and Future Directions.
- 1 Jul 2026
- Drugs